Kurabo Industries (3106) Q4 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2024 earnings summary
23 Oct, 2026Executive summary
FY24 revenue fell 1.4% YoY to ¥151.3bn, while operating income rose 5.9% to ¥9.2bn and net income rose 22.1% to ¥6.7bn; each consolidated profit measure reached a record.
Earnings resilience in chemicals and environmental mechatronics offset a textile downturn; FY25 guidance anticipates a textile return to profitability and modest consolidated growth.
Financial highlights
FY24 revenue was ¥151,314m, operating income ¥9,186m, ordinary income ¥10,191m and net income attributable to owners ¥6,738m.
Revenue declined ¥2,208m YoY, partly reflecting the deconsolidation of Kurashiki Machinery and customer inventory adjustments in textiles.
FY24 capex was ¥4,959m, down 33.9% versus the revised forecast due to timing shifts; depreciation was ¥5,086m.
Outlook and guidance
FY25 forecast: revenue ¥153.0bn (+1.1%), operating income ¥9.3bn (+1.2%), ordinary income ¥10.2bn (+0.1%) and net income ¥7.2bn (+6.8%).
FY25 capex is forecast at ¥9.5bn (+91.6% YoY), with depreciation of ¥5.4bn (+6.2%).
FY25 annual dividend forecast is ¥120 per share, including an interim dividend of ¥60; FY24 paid ¥100 per share.
Latest events from Kurabo Industries
- H1 operating profit grew 13.8%, while investments target semiconductor and solar-material growth.3106
Q2 2024 - Sales and profits grew strongly, but net income fell on lower extraordinary gains; outlook revised up.3106
Q1 2027 - Net profit jumped 42.8% on extraordinary gains, with record FY3/27 growth forecast.3106
Q4 2026 - Q1 profit more than doubled year-over-year, with upwardly revised full-year guidance.3106
Q1 2025 - Record H1 profits on lower revenue; FY guidance held as shareholder returns rose.3106
Q2 2025 - Net income surged 36.8% year-over-year on higher margins, despite a 1.0% revenue decline.3106
Q3 2025 - FY3/25 profits rose; FY3/26 guidance signals headwinds as Accelerate ’27 targets 10% ROE.3106
Q4 2025 - Net income surged on extraordinary gains, but segment results and legal risks warrant caution.3106
Q1 2026 - Attributable profit jumped 87.5% on cross-shareholding gains despite lower sales.3106
Q2 2026